Maternal HIV infection and placental malaria reduce transplacental antibody transfer and tetanus antibody levels in newborns in Kenya

Journal of Infectious Diseases

Volumn 196, Issue 4, 2007, Pages 550-557

  Cumberland, Phillippa ^a   Shulman, Caroline E ^b,f   Maple, P A Chris ^c   Bulmer, Judith N ^e   Dorman, Edgar K ^d,f   Kawuondo, Ken ^f   Marsh, Kevin ^f   Cutts, Felicity T ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d HOMERTON UNIVERSITY HOSPITAL   (United Kingdom)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

^f KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; TETANUS ANTIBODY; TETANUS TOXOID;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; BIOPSY; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KENYA; MAJOR CLINICAL STUDY; MALARIA; MATERNAL DISEASE; MATERNAL SERUM; NEWBORN; NONHUMAN; PASSIVE IMMUNIZATION; PLACENTA; PRIORITY JOURNAL; SELF REPORT; TETANUS; UMBILICAL CORD BLOOD;

ADOLESCENT; ADULT; ANIMALS; ANTIBODIES, BACTERIAL; BIOPSY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FETAL BLOOD; HIV; HIV INFECTIONS; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; INFANT, NEWBORN; KENYA; MALARIA, FALCIPARUM; PLACENTA; PLASMODIUM FALCIPARUM; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; TETANUS; TETANUS ANTITOXIN; TETANUS TOXOID; VACCINATION;

EID: 34547637641     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/519845     Document Type: Article

References (29)

1. Henderson RH, Keja J, Hayden G, Galazka A, Clements J, Chan C. Immunizing the children of the world: progress and prospects. Bull World Health Organ 1988; 66:535-43.
2. Schofield FD, Tucker VM, Westwook GR. Neonatal tetanus in New Guinea. BMJ 1961; 2:785-9.
3. Newell KW, Duenas Lehmann A, LeBlanc DR, Garces Osorio N. The use of tetanus toxoid for the prevention of neonatal tetanus in developing countries. Bull World Health Organ 1966; 35:863-71.
4. Galazka A. The immunological basis for immunization series - module 3: tetanus. Document no. WHO/EPI/GEN/93.13. Geneva: World Health Organization Expanded Programme on Immunization, 1993:3-22.
5. Toivanen P, Mantyjarvi R, Hirvoven T. Maternal antibodies in human foetal sera at different stages of gestation. Immunology 1968; 15:395-403.
6. Gendrel D, Richard-Lenoble D, Massamba MB, Picaud A, Francoual C, Blot P. Placental transfer of tetanus antibodies and protection of the newborn. J Trop Pediatr 1990; 36:279-82.
7. Scott S, Cumberland P, Shulman CE, et al. Neonatal measles immunity in rural Kenya: the influence of HIV and placental malaria infections on placental transfer of antibodies and levels of antibody in maternal and cord serum samples. J Infect Dis 2005; 191:1854-60.
8. Brabin BJ. The influence of malaria and gestation on the immune response to one and two doses of adsorbed tetanus toxoid in pregnancy. Bull World Health Organ 1984; 62:919-30.
9. Brabin BJ, Brabin L, Ginny M, Eggelte T, Van der Kaay HJ, Alpers MP. Failure of chloroquine prophylaxis in Madang, Papua New Guinea. Ann Trop Med Parasitol 1990; 84:1-9.
10. Brair M-E, Brabin BJ, Milligan P, Maxwell S, Hart CA. Reduced transfer of tetanus antibodies with placental malaria. Lancet 1994; 343:208-9.
11. Moraes-Pinto MI, Verhoeff F, Chimsuku L, et al. Placental antibody transfer: influence of maternal HIV infection and placental malaria. Arch Dis Child Fetal Neonatal Ed 1998; 79:F202-5.
12. Okoko BJ, Lalanga H, Wesumperuma L, et al. Influence of placental malaria infection and maternal hypergammaglobulinemia on materno-foetal transfer of measles and tetanus antibodies in a rural West African population. J Health Popul Nutr 2001; 19:59-65.
13. Moss WJ, Clements J, Halsey NA. Immunization of children at risk of infection with human immunodeficiency virus. Bull World Health Organ 2003; 81:61-70.
14. Borkowsky W, Steele CJ, Grubman S, Moore T, La Russa P, Kransinski K. Antibody responses to bacterial toxoids in children infected with human immunodeficiency virus. J Pediatr 1987; 110:563-6.
15. Borkowsky W, Rigaud M, Kransinski K, Moore T, Lawrence R, Pollack H. Cell-mediated and humoral immune responses in children infected with human immunodeficiency virus during the first four years of life. J Pediatr 1992; 120:371-5.
16. Bernstein LJ, Ochs HD, Wedgewood RJ, Rubinstein A. Defective humoral immunity in pediatric acquired immune deficiency syndrome. J Pediatr 1985; 107:352-7.
17. Dieye TN, Sow PS, Simonart T, et al. Immunologic and virologic response after tetanus toxoid booster among HIV-1- and HIV-2-infected Senegalese individuals. Vaccine 2001; 20:905-13.
18. Mbogo CNM, Snow RW, Khamala CPM, et al. Relationship between Plasmodium falciparum transmission by vector populations and the incidence of severe disease at nine sites on the Kenyan coast. Am J Trop Med Hyg 1995; 52:201-6.
19. Snow RW, Schellenberg JR, Peshu N, et al. Periodicity and space-time clustering of severe childhood malaria on the coast of Kenya. Trans R Soc Trop Med Hyg 1993; 87:386-90.
20. Shulman CE, Marshall T, Dorman EK, et al. Malaria in pregnancy: adverse effects on haemoglobin levels and birthweight in primigravidae and multigravidae. Trop Med Int Health 2001; 6:770-8.
21. Shulman CE, Dorman EK, Cutts F, et al. Intermittent sulphadoxine- pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial. Lancet 1999; 353:632-6.
22. Parry JV, Mortimer PP. An immunoglobulin G antibody capture particle-adherence test (GACPAT) for antibody to HIV-1 and HTLV-1 that allows economical large-scale screening. AIDS 1989; 3:173-6.
23. Eregie CO, Muogbo DC. A simplified method of estimating gestational age in an African population. Dev Med Child Neurol 1991; 33:146-52.
24. Melville-Smith ME, Seagrott VA, Watkins JT. A comparison of enzyme-linked immunosorbent assay (ELISA) with the toxin neutralization test in mice as a method for the estimation of tetanus antitoxin in human sera. J Biol Stand 1983; 11:137-44.
25. Maple PA, Jones CS, Wall EC, et al. Immunity to diphtheria and tetanus in England and Wales. Vaccine 2000; 19:167-73.
26. World Health Organization. Tetanus vaccine. Wkly Epidemiol Rec 2006; 81:198-208.
27. Bonetti TCS, Succi RCM, Weckx LY, Tavares-Lopes L, Moraes-Pinto MI. Tetanus and diphtheria antibodies and response to a booster dose in Brazilian HIV-1-infected women. Vaccine 2004; 22:3707-12.
28. de Moraes-Pinto MI, Almeida AC, Kenj G, et al. Placental transfer and maternally acquired neonatal IgG immunity in human immunodeficiency virus infection. J Infect Dis 1996; 173:1077-84.
29. Cutts FT, Rodrigues LC, Colombo S, Bennett S. Evaluation of factors influencing vaccine uptake in Mozambique. Int J Epidemiol 1989; 18: 427-33.